Technologies related to Central Nervous System

Novel Methods for Reducing Inflammation and Treating Diseases such as Parkinson's and Alzheimer's Disease
Ref: E-130-2004-0 | Updated: Mar 10, 2021
Assay for Predicting the Time of Onset of Niemann-Pick Disease Type C (NPC)
Ref: E-060-2013-0 | Updated: Sep 28, 2020
A Rapid Ultrasensitive Assay for Detecting Prions Based on the Seeded Polymerization of Recombinant Normal Prion Protein (rPrP-sen)
Ref: E-109-2007-0 | Updated: May 29, 2020
Gene Therapy for Niemann-Pick Disease Type C
Ref: E-185-2014-0 | Updated: Sep 28, 2020
Fluorescent Primer(s) Creation for Nucleic Acid Detection and Amplification
Ref: E-252-2013-0 | Updated: Mar 9, 2020
Photoinduced Electron Transfer Fluorescent Primer for Nucleic Acid Amplification
Ref: E-292-2013-0 | Updated: Mar 9, 2020
Handwipe Disclosing Method for Detecting the Presence of Lead
Ref: E-336-2013-0 | Updated: Feb 13, 2020
Wipes and Methods for Removal of Lead and Other Metal Contamination from Surfaces
Ref: E-221-2013-0 | Updated: Feb 13, 2020
A New Class of Immunomodulatory Drugs for Multiple Sclerosis
Ref: E-064-2015-0 | Updated: Oct 2, 2018
Licensing Availability: Methods of Diagnosing and Treating CHAPLE, A Newly Identified Orphan Disease
Ref: E-251-2016-0 | Updated: Sep 7, 2018
A Novel Reagent for Labeling PET Tracers at Trifluoromethyl Groups
Ref: E-259-2016-0 | Updated: Jun 28, 2018
Novel Magnetic Resonance Spectroscopy (MRS) Technique to Quantify Brain Metabolites
Ref: E-206-2017-0 | Updated: May 23, 2018
Human fMLP Receptor / FPR cDNA
Ref: B-007-1995-0 | Updated: Dec 4, 2017
Human FPRL1 / FPR2 cDNA
Ref: B-008-1995-0 | Updated: Dec 4, 2017
M5 Muscarinic Receptor Knockout (Chrm5tm1Jwe) Mouse Model for Neurological Studies
Ref: E-110-2012-0 | Updated: Apr 17, 2017
Long Acting Therapeutic Conjugates with Evans Blue
Ref: E-143-2015-0 | Updated: Jun 27, 2016
Detection and Discrimination of Classical and Atypical L-Type BSE Strains by RT-QuIC
Ref: E-048-2015-0 | Updated: May 7, 2018
mNFHcre Transgenic Mice
Ref: E-293-2009-0 | Updated: Aug 10, 2015
A Novel Adeno-Associated Virus for Gene Therapy
Ref: E-175-2015-0 | Updated: May 1, 2019
Magnetic Resonance Magnification Imaging
Ref: E-252-2014-0 | Updated: Jan 12, 2017
Device for Selective Partitioning of Frozen Cellular Products
Ref: E-173-2009-0 | Updated: Jun 29, 2015
Novel Dopamine D2 Receptor Antagonists and Methods of Their Use
Ref: E-030-2013-0 | Updated: Sep 5, 2017
Mobile Instrumentation for the Detection and Sampling of Aerosol Particles
Ref: E-026-2014-0 | Updated: Nov 14, 2014
Miniature Serial Microtome for Block-Face Imaging
Ref: E-121-2014-0 | Updated: May 14, 2018
A Novel Demodulation System in X-ray Imaging
Ref: E-113-2013-0 | Updated: May 18, 2018
Monitoring the Effects of Sleep Deprivation Using Neuronal Avalanches
Ref: E-345-2013-0 | Updated: Aug 17, 2016
Compositions for Modification of Genomic DNA and Exogenous Gene Expression
Ref: E-763-2013-0 | Updated: May 14, 2018
Engineering Neural Stem Cells Using Homologous Recombination
Ref: E-762-2013-0 | Updated: May 14, 2018
Human iPSC-Derived Mesodermal Precursor Cells and Differentiated Cells
Ref: E-342-2013-0 | Updated: May 14, 2018
Methods for Amelioration and Treatment of Pathogen-associated Inflammatory Response
Ref: E-236-2013-0 | Updated: Feb 19, 2014
Cylindrical Handle Dynamometer for Improved Grip-Strength Measurement
Ref: E-143-2013-0 | Updated: Feb 6, 2014
Automated Microscopic Image Acquisition, Compositing and Display Software Developed for Applied Microscopy/Cytology Training and Analysis
Ref: E-228-2013-0 | Updated: Feb 6, 2014
Methods of Retaining Methylation Pattern Information in Globally Amplified DNA
Ref: E-243-2013-0 | Updated: Feb 6, 2014
Therapeutic, Bifunctional Janus Microparticles with Spatially Segregated Surface Proteins and Methods of Production
Ref: E-457-2013-1 | Updated: Jan 28, 2014
Use of Detector Response Curves to Optimize Settings for Mass Spectrometry
Ref: E-157-2013-0 | Updated: Jan 20, 2014
Methods of Treating or Preventing Pruritis (Itch)
Ref: E-485-2013-0 | Updated: Jun 7, 2018
Generation of Artificial Mutation Controls for Diagnostic Testing
Ref: E-255-2013-0 | Updated: May 24, 2016
Diffusion Through Skull as Route of Delivery for Treatment of Brain Injury and Disease
Ref: E-025-2012-0 | Updated: Aug 6, 2013
Live Attenuated RSV Vaccines Based on Codon-Pair Deoptimization
Ref: E-080-2013-0 | Updated: Jun 6, 2013
Derivatives of Docosahexaenoylethanolamide (DEA) for Neurogenesis
Ref: E-070-2012-0 | Updated: Nov 1, 2017
SIRT2 Inhibitors as Novel Therapeutics for Myocardial Infarction and Ischemic Stroke and to Prevent Necrosis
Ref: E-003-2013-0 | Updated: May 9, 2018
Axon Regeneration After Brain or Spinal Cord Injury
Ref: E-214-2012-0 | Updated: Nov 21, 2012
Small Molecule MRS5474 with Anticonvulsant Activity for Treatment of Epilepsy
Ref: E-285-2008-1 | Updated: Aug 31, 2016
Glucocerebrosidase Non-inhibitory Chaperones for the Treatment of Gaucher Disease, Parkinson's Disease, and Other Proteinopathies
Ref: E-144-2012-0 | Updated: May 1, 2018
Cyclodextrins as Therapeutics for Lysosomal Storage Disorders
Ref: E-050-2012-0 | Updated: Nov 18, 2015
Novel Radio-labeled Agents for Imaging Alzheimer's Disease-associated Amyloid
Ref: E-225-2011-0 | Updated: Aug 17, 2016
Encapsulated N-Acetylmannosamine or N-Acetylneuraminic Acid as a Therapeutic Agent for Increasing Sialylation in Certain Muscular Atrophies, Kidney Disorders, Cancers or Poor Immune Function
Ref: E-270-2011-0 | Updated: Sep 21, 2015
Therapeutic Approach to Neurodegenerative Disorders Using a TFP5-Peptide
Ref: E-144-2010-0 | Updated: May 5, 2016
Phantasmidine, a Nicotinic Receptor Agonist for the Treatment of Addiction and Neurological Disorders
Ref: E-125-2010-0 | Updated: Sep 20, 2010
Prevention and Treatment of Multiple Sclerosis (MS) by Administering E-Selectin
Ref: E-153-2005-0 | Updated: Jun 16, 2010
Treatment of Alcoholism by Inhibition of the Neuropeptide Y Receptor
Ref: E-101-2004-0 | Updated: Aug 1, 2008
A Neuronal Avalanche Size (NAS) Assay to Screen for Cognitive Enhancers and Anti-Epileptics
Ref: E-294-2005-1 | Updated: Sep 24, 2015
Serotonin-Deficient Knock-out Mouse
Ref: B-019-1999-0 | Updated: Jun 5, 2018
Beta-Amyloid and Tau Fibril Positron Emissions Tomography (PET) Imaging Agents
Ref: E-156-2006-0 | Updated: Aug 17, 2016
Rapid Anti-Depressant Response Produced by Low Dose Treatment with Anti-Muscarinic Drugs
Ref: E-175-2004-0 | Updated: May 24, 2016
Genes For Niemann-Pick Type C Disease
Ref: E-122-1997-0 | Updated: May 15, 2016
AAV4 Vector and Uses Thereof
Ref: E-071-2000-0 | Updated: May 9, 2018
AAV5 Vector for Transducing Brain Cells and Lung Cells
Ref: E-072-2000-0 | Updated: May 9, 2018
Pain Control by the Selective Local Ablation of Nociceptive Neurons
Ref: E-109-2000-0 | Updated: Dec 1, 2003
Enhanced Distribution of Therapeutic Agents After Local Delivery
Ref: E-206-2000-0 | Updated: May 1, 2002
Batrachotoxins as Unique Activators of Sodium Channels
Ref: | Updated: Sep 1, 2001
Immunoglobulin-G Constant Region Fusion Proteins as Molecular Weight Markers
Ref: | Updated: Dec 1, 2000
PTH2 and PTH1 Receptor Ligands
Ref: E-123-1999-0 | Updated: Nov 18, 2015
Virally Mediated Gene Therapy For The Control Of Chronic Or Persistent Pain
Ref: E-044-1998-0 | Updated: May 6, 2018
Cell Expansion System For Use In Neural Transplantation
Ref: E-235-1998-0 | Updated: Feb 1, 1999
2,2'-Bipyridyl, a Ferrous Chelator, Prevents Vasospasm in a Primate Model of Subarachnoid Hemorrhage
Ref: E-050-1996-0 | Updated: Jan 1, 1997
cDNA Sequence of a Clone Encoding Arylalkylamine N-acetyltransferase and Human Gene Encoding Serotonin N-acetyltransferase
Ref: | Updated: Dec 1, 1995
Subscribe to Technologies related to Central Nervous System